Easywell Biomedicals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-73.14	-97.47	-144.82	-161	-150.39
Depreciation & Amortization	91.13	79.78	65.13	66.55	70.78
Other Amortization	-	0.1	0.02	-	0.1
Loss (Gain) From Sale of Assets	-0.18	-0.03	-	-	-0.24
Stock-Based Compensation	3.66	12.44	16.96	-	-
Provision & Write-off of Bad Debts	-2.65	4.98	-	-	-
Other Operating Activities	-11.61	9.24	-25.14	-7.46	-37.23
Change in Accounts Receivable	4.43	23.38	-47.17	13.08	-5.66
Change in Inventory	96.16	-213.19	-15.59	-3.92	9.95
Change in Accounts Payable	-36.01	35.53	7.17	1.78	0.08
Change in Unearned Revenue	34.94	-8.54	5.7	20.56	-4.08
Change in Other Net Operating Assets	38.31	14.9	-13.72	1.9	3.39
Operating Cash Flow	124.78	-159.04	-151.45	-53.5	-128.31
Capital Expenditures	-15.41	-12.49	-17.73	-7.49	-7.71
Sale of Property, Plant & Equipment	0.18	0.08	-	-	0.24
Sale (Purchase) of Intangibles	-	-0.26	-0.82	-	-
Investment in Securities	-9.84	-35.15	106.38	80.14	-175.07
Other Investing Activities	0.03	0.17	-0.37	0.01	-
Investing Cash Flow	-25.04	-47.66	87.46	72.66	-182.54
Short-Term Debt Issued	86.58	200.1	43.93	-	-
Total Debt Issued	86.58	200.1	43.93	-	-
Short-Term Debt Repaid	-194.4	-44.56	-	-	-
Long-Term Debt Repaid	-17.16	-14.19	-15.47	-10.55	-9.45
Total Debt Repaid	-211.56	-58.75	-15.47	-10.55	-9.45
Net Debt Issued (Repaid)	-124.98	141.34	28.46	-10.55	-9.45
Issuance of Common Stock	169.17	171.84	15	-	329.76
Repurchase of Common Stock	-	-0.75	-	-	-
Other Financing Activities	-186.89	-49.37	134.39	-	-
Financing Cash Flow	-142.7	263.06	177.84	-10.55	320.31
Foreign Exchange Rate Adjustments	-1.64	6.41	-9.98	-2.61	-1.33
Net Cash Flow	-44.6	62.76	103.88	6	8.14
Free Cash Flow	109.37	-171.53	-169.17	-60.99	-136.02
Free Cash Flow Margin	18.31%	-31.74%	-62.28%	-34.09%	-68.95%
Free Cash Flow Per Share	0.88	-1.43	-1.48	-0.53	-1.28
Cash Interest Paid	22.45	21.34	19.03	17.25	16.08
Cash Income Tax Paid	0.25	0.42	0.42	0.19	0.84
Levered Free Cash Flow	89.05	-42.68	-117.85	-28.28	-79.6
Unlevered Free Cash Flow	103.1	-29.46	-105.81	-17.5	-69.55
Change in Working Capital	117.56	-168.08	-63.6	48.41	-11.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.